Skip to main content

previous disabled Page of 13
and
  1. Article

    Open Access

    Correction: MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma

    Qin Tang, Wan Li, **ang** Zheng, Liwen Ren in Signal Transduction and Targeted Therapy (2024)

  2. Article

    Open Access

    A Cullin 5-based complex serves as an essential modulator of ORF9b stability in SARS-CoV-2 replication

    The ORF9b protein, derived from the nucleocapsid’s open-reading frame in both SARS-CoV and SARS-CoV-2, serves as an accessory protein crucial for viral immune evasion by inhibiting the innate immune response. ...

    Yuzheng Zhou, Zongpeng Chen, Sijie Liu in Signal Transduction and Targeted Therapy (2024)

  3. Article

    Open Access

    Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancer

    Pancreatic cancer is one of the deadly malignancies with a significant mortality rate and there are currently few therapeutic options for it. The tumor microenvironment (TME) in pancreatic cancer, distinguishe...

    Pengcheng Zhou, Xuanlong Du, Weilu Jia in Signal Transduction and Targeted Therapy (2024)

  4. Article

    Open Access

    First-line penpulimab (an anti-PD1 antibody) and anlotinib (an angiogenesis inhibitor) with nab-paclitaxel/gemcitabine (PAAG) in metastatic pancreatic cancer: a prospective, multicentre, biomolecular exploratory, phase II trial

    Metastatic pancreatic cancer (mPC) has a dismal prognosis. Herein, we conducted a prospective, multicentre, single-arm, phase II trial evaluating the efficacy and safety of penpulimab and anlotinib in combinat...

    Huizi Sha, Fan Tong, Jiayao Ni, Yi Sun in Signal Transduction and Targeted Therapy (2024)

  5. No Access

    Article

    ZBTB16 inhibits DNA replication and induces cell cycle arrest by targeting WDHD1 transcription in lung adenocarcinoma

    Lung adenocarcinoma is a malignant tumor with high morbidity and mortality. ZBTB16 plays a double role in various tumors; however, the potential mechanism of ZBTB16 in the pathophysiology of lung adenocarcinom...

    Kai Wang, Deyu Guo, Tao Yan, Shijie Sun, Yadong Wang, Haotian Zheng in Oncogene (2024)

  6. Article

    Open Access

    An E3 ligase TRIM1 promotes colorectal cancer progression via K63-linked ubiquitination and activation of HIF1α

    Accumulating studies have shown that E3 ligases play crucial roles in regulating cellular biological processes and signaling pathways during carcinogenesis via ubiquitination. Tripartite-motif (TRIM) ubiquitin...

    Liuliu Shi, **anglan Fang, Lijie Du, ** Yang, Juan Xue, **aokai Yue in Oncogenesis (2024)

  7. No Access

    Article

    False-positive human immunodeficiency virus nuclear acid amplification technique testing following therapy with transgenic T cell receptor cellular therapy for synovial sarcoma

    Michael Slade, Dejka Araujo, Min Du, Bijal Parikh in Bone Marrow Transplantation (2024)

  8. Article

    Open Access

    LncRNA MIR31HG fosters stemness malignant features of non-small cell lung cancer via H3K4me1- and H3K27Ace-mediated GLI2 expression

    Non-coding RNAs are responsible for oncogenesis and the development of stemness features, including multidrug resistance and metastasis, in various cancers. Expression of lncRNA MIR31HG in lung cancer tissues ...

    Weiwei Chen, Fei Wang, **nyuan Yu, **g**g Qi, Hongliang Dong, Bingjie Cui in Oncogene (2024)

  9. No Access

    Article

    Targeting STING elicits GSDMD-dependent pyroptosis and boosts anti-tumor immunity in renal cell carcinoma

    While Stimulator-of-interferon genes (STING) is an innate immune adapter cruicial for sensing cytosolic DNA and modulating immune microenvironment, its tumor-promoting role in tumor survival and immune evasion...

    Shengpan Wu, Baojun Wang, Hongzhao Li, Hanfeng Wang, Songliang Du, **ng Huang in Oncogene (2024)

  10. Article

    Open Access

    XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial

    Fluoropyrimidine-based combination chemotherapy plus targeted therapy is the standard initial treatment for unresectable metastatic colorectal cancer (mCRC), but the prognosis remains poor. This phase 3 trial ...

    Qiu-Zhong Pan, **g-**g Zhao, Liang Liu in Signal Transduction and Targeted Therapy (2024)

  11. Article

    Correction: M7G modification of FTH1 and pri-miR-26a regulates ferroptosis and chemotherapy resistance in osteosarcoma

    Mingyu He, Yang Wang, Jiajie **e, Jiaying Pu, Zhihua Shen, Ao Wang, Tao Li in Oncogene (2024)

  12. Article

    Open Access

    RIOK3 sustains colorectal cancer cell survival under glucose deprivation via an HSP90α-dependent pathway

    Glucose oxidation via the pentose phosphate pathway serves as the primary cellular mechanism for generating nicotinamide adenine dinucleotide phosphate (NADPH). The central regions of solid tumors typically ex...

    Nan Zhang, Lu Dong, Tingting Ning, Feng Du, Mengran Zhao, Junxuan Xu in Oncogenesis (2024)

  13. No Access

    Article

    TRAIP suppresses bladder cancer progression by catalyzing K48-linked polyubiquitination of MYC

    TRAF-interacting protein (TRAIP), an E3 ligase containing a RING domain, has emerged as a significant contributor to maintaining genome integrity and is closely associated with cancer. Our study reveals that T...

    **gtian Yu, Mingxing Li, Lingao Ju, Fenfang Zhou, Ye**peng Wang, Yi Zhang in Oncogene (2024)

  14. Article

    Open Access

    Neddylation is a novel therapeutic target for lupus by regulating double negative T cell homeostasis

    Systemic lupus erythematosus (SLE), a severe autoimmune disorder, is characterized by systemic inflammatory response, autoantibody accumulation and damage to organs. The dysregulation of double-negative (DN) T...

    Yun Zhang, Lijun Du, Chenxi Wang in Signal Transduction and Targeted Therapy (2024)

  15. Article

    Open Access

    Camouflaging attenuated Salmonella by cryo-shocked macrophages for tumor-targeted therapy

    Live bacteria-mediated antitumor therapies mark a pivotal point in cancer immunotherapy. However, the difficulty in reconciling the safety and efficacy of bacterial therapies has limited their application. Imp...

    Leyang Wu, Zengzheng Du, Lin Li, Liyuan Qiao in Signal Transduction and Targeted Therapy (2024)

  16. Article

    Open Access

    A cyclin D1 intrinsically disordered domain accesses modified histone motifs to govern gene transcription

    The essential G1-cyclin, CCND1, is frequently overexpressed in cancer, contributing to tumorigenesis by driving cell-cycle progression. D-type cyclins are rate-limiting regulators of G1-S progression in mammalian...

    Xuanmao Jiao, Gabriele Di Sante, Mathew C. Casimiro, Agnes Tantos in Oncogenesis (2024)

  17. Article

    Open Access

    Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity

    Non-small cell lung cancer (NSCLC) ranks as one of the leading causes of cancer-related deaths worldwide. Despite the prominence and effectiveness of kinase-target therapies in NSCLC treatment, these drugs are...

    Tao Yuan, Chenming Zeng, Jiawei Liu in Signal Transduction and Targeted Therapy (2024)

  18. No Access

    Article

    M7G modification of FTH1 and pri-miR-26a regulates ferroptosis and chemotherapy resistance in osteosarcoma

    Doxorubicin and platinum are widely used in the frontline treatment of osteosarcoma, but resistance to chemotherapy limits its curative effect. Here, we have identified that METTL1 mediated N7-Methyladenosine (m7

    Mingyu He, Yang Wang, Jiajie **e, Jiaying Pu, Zhihua Shen, Ao Wang, Tao Li in Oncogene (2024)

  19. No Access

    Article

    USP11 potentiates HGF/AKT signaling and drives metastasis in hepatocellular carcinoma

    USP11 is a member of the ubiquitin-specific protease family and plays a crucial role in tumor progression in various cancers. However, the precise mechanism by which USP11 promotes EMT and metastasis in hepato...

    ** Chen, Deng Ning, Pengcheng Du, Qiumeng Liu, Jie Mo, Huifang Liang in Oncogene (2024)

  20. Article

    Open Access

    Trogocytosis of CAR molecule regulates CAR-T cell dysfunction and tumor antigen escape

    Chimeric antigen receptor (CAR) T-cell therapy has demonstrated clinical response in treating both hematologic malignancies and solid tumors. Although instances of rapid tumor remissions have been observed in ...

    You Zhai, Yicong Du, Guanzhang Li, Mingchen Yu in Signal Transduction and Targeted Therapy (2023)

previous disabled Page of 13